Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Surmodics Inc
(NQ:
SRDX
)
38.49
+0.83 (+2.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Surmodics Inc
< Previous
1
2
3
4
Next >
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
January 19, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
January 16, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
November 17, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
November 11, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
November 09, 2022
From
Surmodics, Inc.
Via
Business Wire
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
November 02, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
October 28, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
October 26, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing
October 17, 2022
From
Surmodics, Inc.
Via
Business Wire
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
October 11, 2022
From
Surmodics, Inc.
Via
Business Wire
6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe
October 07, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
August 23, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Third Quarter Fiscal 2022 Results
July 27, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27
July 19, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Present at Jefferies Healthcare Conference
June 01, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Second Quarter Fiscal 2022 Results
April 27, 2022
From
Surmodics, Inc.
Via
Business Wire
Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases
April 27, 2022
From
Surmodics, Inc.
Via
Business Wire
Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
April 25, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27
April 19, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Host Virtual Annual Meeting of Shareholders
February 04, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports First Quarter Fiscal 2022 Results
February 03, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3
January 26, 2022
From
Surmodics, Inc.
Via
Business Wire
Sidoti Winter Virtual Small Cap Investor Conference
January 18, 2022
- Presentation Times and Weblinks Released for Over 70 Presenting Companies - Wednesday and Thursday, January 19th-20th, 2022 NEW YORK, NY / ACCESSWIRE / January 18, 2022 / Sidoti & Company, LLC has...
From
Sidoti & Company, LLC
Via
AccessWire
Surmodics to Present at Sidoti & Company Virtual Investor Conference
January 11, 2022
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance
November 10, 2021
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Webcast Fourth Quarter Fiscal 2021 Earnings Conference Call on November 10
November 02, 2021
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter
September 29, 2021
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
August 04, 2021
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces Successful First Patient Use of Pounce™ Thrombectomy System
July 29, 2021
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
July 27, 2021
From
Surmodics, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.